Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocon | BSE | Healthcare | Biotechnology & Medical Research | ₹536.04B | 46.8x | -55.64 | ₹398.60 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.1% Upside | Upgrade to Pro+ | |
Biocon | NSE | Healthcare | Biotechnology & Medical Research | ₹534.50B | 46.8x | -55.59 | ₹400.70 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
Syngene International Ltd BO | BSE | Healthcare | Biotechnology & Medical Research | ₹266.13B | 54.4x | ₹667.50 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | ||
Syngene International Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹266.13B | 54.4x | ₹668.25 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | ||
Suven Life Sciences | BSE | Healthcare | Biotechnology & Medical Research | ₹63.24B | -39.5x | 0.74 | ₹287 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suven Life Sciences Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹63.22B | -39.5x | 0.74 | ₹289.88 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shree Ganesh Remedies | BSE | Healthcare | Biotechnology & Medical Research | ₹7.71B | 33.9x | -1.74 | ₹600.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Indo Us Bio-Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹3.81B | 21.4x | 0.22 | ₹190.80 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions | BSE | Healthcare | Biotechnology & Medical Research | ₹1.43B | 55.5x | 0.4 | ₹9.83 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹1.43B | 55.5x | 0.4 | ₹9.77 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivo Bio Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹722M | 7.7x | 0.05 | ₹36.10 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jeevan Scientific Technology | BSE | Healthcare | Biotechnology & Medical Research | ₹633.04M | 479.1x | 4.42 | ₹39.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transgene Biotek | BSE | Healthcare | Biotechnology & Medical Research | ₹389.46M | -56.6x | ₹5.14 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Vanta Bioscience | BSE | Healthcare | Biotechnology & Medical Research | ₹185.19M | -4.5x | -0.35 | ₹29.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |